Liven Pharma Limited (PSX:LIVEN)
Pakistan
· Delayed Price · Currency is PKR 30.25
-2.43 (-7.44%)
At close: Mar 9, 2026
Liven Pharma Ratios and Metrics
Market cap in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 3,419 | 6,042 | 110 | 185 | 152 | 303 | Upgrade
|
| Market Cap Growth | 157.02% | 5370.54% | -40.46% | 21.91% | -49.80% | 127.48% | Upgrade
|
| Enterprise Value | 3,448 | 6,080 | 349 | 423 | 387 | 535 | Upgrade
|
| Last Close Price | 30.25 | 55.17 | 7.74 | 13.00 | 10.66 | 21.24 | Upgrade
|
| PE Ratio | - | - | 2.65 | - | - | - | Upgrade
|
| PS Ratio | 40.41 | 47.47 | 0.45 | - | - | - | Upgrade
|
| PB Ratio | 5.41 | 9.53 | 0.15 | -1.51 | -1.38 | -3.16 | Upgrade
|
| P/TBV Ratio | 5.47 | 9.66 | 0.15 | - | - | - | Upgrade
|
| P/FCF Ratio | - | - | 8.00 | - | - | - | Upgrade
|
| P/OCF Ratio | 269.45 | - | 8.00 | - | - | - | Upgrade
|
| EV/Sales Ratio | 40.74 | 47.77 | 1.42 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | - | - | 5.37 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 8.35 | - | - | - | Upgrade
|
| EV/FCF Ratio | -137.99 | - | 25.26 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.06 | 0.21 | -1.94 | -2.13 | -2.43 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 2.35 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 11.37 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.05 | 0.04 | 0.18 | -1.94 | -2.13 | -2.43 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.06 | -0.06 | 2.03 | -111.87 | -79.65 | -110.82 | Upgrade
|
| Net Debt / FCF Ratio | -1.13 | -1.09 | 9.56 | -104.83 | -104.11 | -34.31 | Upgrade
|
| Asset Turnover | 0.10 | 0.14 | 0.46 | - | - | - | Upgrade
|
| Inventory Turnover | 0.65 | 0.90 | - | - | - | - | Upgrade
|
| Quick Ratio | 0.10 | 0.19 | 0.71 | 0 | 0 | 0 | Upgrade
|
| Current Ratio | 1.34 | 1.64 | 1.48 | 0 | 0 | 0.00 | Upgrade
|
| Return on Equity (ROE) | -91.87% | -84.49% | 13.31% | - | - | - | Upgrade
|
| Return on Assets (ROA) | -37.42% | -35.12% | 4.93% | -6.89% | -7.20% | -6.80% | Upgrade
|
| Return on Capital Employed (ROCE) | -75.50% | -67.10% | 5.60% | 14.20% | 19.10% | 24.50% | Upgrade
|
| Earnings Yield | -20.64% | -9.67% | 37.80% | -6.65% | -9.39% | -4.83% | Upgrade
|
| FCF Yield | -0.73% | -0.41% | 12.50% | -1.22% | -1.49% | -2.24% | Upgrade
|
| Buyback Yield / Dilution | -417.79% | -174375.69% | 99.67% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.